Showing 1 - 1 results of 1 for search '"metabolic dysfunction-associated steatohepatitis (mash)"', query time: 0.03s Refine Results
  1. 1
    FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management

    FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management by Muhammad Mazhar Azam, Sameen Mukhtar, Muhammad Haris, Fatima Laique, Suhaina Amir, Mubashir Mohiuddin, Bibek Giri

    Published 2024-12-01
    Subjects: “…metabolic dysfunction-associated steatohepatitis (mash)…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: